Matthew Huber1, Tezcan Ozrazgat-Baslanti1, Paul Thottakkara1, Philip A Efron2, Robert Feezor2, Charles Hobson3, Azra Bihorac4. 1. Department of Anesthesiology, University of Florida, Gainesville, FL. 2. Department of Surgery, University of Florida, Gainesville, FL. 3. Department of Surgery, Malcom Randall VA Medical Center, Gainesville, FL; Department of Health Services Research, Management, and Policy, University of Florida, Gainesville, FL. 4. Department of Anesthesiology, University of Florida, Gainesville, FL. Electronic address: abihorac@anest.ufl.edu.
Abstract
BACKGROUND: Both acute kidney injury (AKI) and chronic kidney disease (CKD) are common yet underappreciated risk factors for adverse perioperative outcomes. We hypothesize that AKI and CKD are associated with similar increases in 90-day mortality and cost in patients undergoing major vascular surgery. METHODS: We used multivariable regression analyses to evaluate the associations between AKI and CKD and incremental 90-day mortality and hospital cost in a single-center cohort of 3646 adult patients undergoing major vascular surgery. We defined AKI using Kidney Disease: Improving Global Outcomes criteria as change in creatinine ≥ 0.3 mg/dL or ≥ 50% increase from the reference value. CKD was determined from medical history. Regression models were adjusted for demographic and socioeconomic characteristics, comorbid conditions, surgery type, and postoperative complications. RESULTS: The prevalence of kidney disease among vascular surgery patients is high with 49% of patients developing AKI during hospitalization and 17% presenting with CKD on admission. In risk-adjusted logistic regression analysis, perioperative AKI (odds ratio 2.2, 95% confidence interval 1.5-3.3) was the most significant predictor of 90-day mortality. The risk-adjusted average cost was significantly higher for patients with any type of kidney disease. The incremental cost of having any type of kidney disease ranged from $9100 to $19,100, even after adjustment for underlying comorbidities and other postoperative complications. CONCLUSIONS: Kidney disease after major vascular surgery is associated with significant increases in 90-day mortality and cost with the highest risk observed among patients with AKI regardless of previous CKD.
BACKGROUND: Both acute kidney injury (AKI) and chronic kidney disease (CKD) are common yet underappreciated risk factors for adverse perioperative outcomes. We hypothesize that AKI and CKD are associated with similar increases in 90-day mortality and cost in patients undergoing major vascular surgery. METHODS: We used multivariable regression analyses to evaluate the associations between AKI and CKD and incremental 90-day mortality and hospital cost in a single-center cohort of 3646 adult patients undergoing major vascular surgery. We defined AKI using Kidney Disease: Improving Global Outcomes criteria as change in creatinine ≥ 0.3 mg/dL or ≥ 50% increase from the reference value. CKD was determined from medical history. Regression models were adjusted for demographic and socioeconomic characteristics, comorbid conditions, surgery type, and postoperative complications. RESULTS: The prevalence of kidney disease among vascular surgery patients is high with 49% of patients developing AKI during hospitalization and 17% presenting with CKD on admission. In risk-adjusted logistic regression analysis, perioperative AKI (odds ratio 2.2, 95% confidence interval 1.5-3.3) was the most significant predictor of 90-day mortality. The risk-adjusted average cost was significantly higher for patients with any type of kidney disease. The incremental cost of having any type of kidney disease ranged from $9100 to $19,100, even after adjustment for underlying comorbidities and other postoperative complications. CONCLUSIONS:Kidney disease after major vascular surgery is associated with significant increases in 90-day mortality and cost with the highest risk observed among patients with AKI regardless of previous CKD.
Authors: Damien J LaPar; Castigliano M Bhamidipati; Carlos M Mery; George J Stukenborg; David R Jones; Bruce D Schirmer; Irving L Kron; Gorav Ailawadi Journal: Ann Surg Date: 2010-09 Impact factor: 12.969
Authors: Thomas G Weiser; Scott E Regenbogen; Katherine D Thompson; Alex B Haynes; Stuart R Lipsitz; William R Berry; Atul A Gawande Journal: Lancet Date: 2008-06-24 Impact factor: 79.321
Authors: Areef Ishani; David Nelson; Barbara Clothier; Tamara Schult; Sean Nugent; Nancy Greer; Yelena Slinin; Kristine E Ensrud Journal: Arch Intern Med Date: 2011-02-14
Authors: Mark Unroe; Jeremy M Kahn; Shannon S Carson; Joseph A Govert; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice Gray; James A Tulsky; Christopher E Cox Journal: Ann Intern Med Date: 2010-08-03 Impact factor: 25.391
Authors: Edward D Siew; T Alp Ikizler; Michael E Matheny; Yaping Shi; Jonathan S Schildcrout; Ioana Danciu; Jamie P Dwyer; Manakan Srichai; Adriana M Hung; James P Smith; Josh F Peterson Journal: Clin J Am Soc Nephrol Date: 2012-03-15 Impact factor: 8.237
Authors: Azra Bihorac; Matthew J Delano; Jesse D Schold; Maria Cecilia Lopez; Avery B Nathens; Ronald V Maier; Abraham Joseph Layon; Henry V Baker; Lyle L Moldawer Journal: Ann Surg Date: 2010-07 Impact factor: 12.969
Authors: Lori F Gentile; Alex G Cuenca; Philip A Efron; Darwin Ang; Azra Bihorac; Bruce A McKinley; Lyle L Moldawer; Frederick A Moore Journal: J Trauma Acute Care Surg Date: 2012-06 Impact factor: 3.313
Authors: Charles E Hobson; Sinan Yavas; Mark S Segal; Jesse D Schold; Curtis G Tribble; A Joseph Layon; Azra Bihorac Journal: Circulation Date: 2009-04-27 Impact factor: 29.690
Authors: Amanda C Filiberto; Tezcan Ozrazgat-Baslanti; Tyler J Loftus; Ying-Chih Peng; Shounak Datta; Philip Efron; Gilbert R Upchurch; Azra Bihorac; Michol A Cooper Journal: Surgery Date: 2021-02-27 Impact factor: 4.348
Authors: Ravindra Mehta; Azra Bihorac; Nicholas M Selby; Hude Quan; Stuart L Goldstein; John A Kellum; Claudio Ronco; Sean M Bagshaw Journal: Can J Kidney Health Dis Date: 2016-02-26
Authors: Mitra K Nadim; Lui G Forni; Azra Bihorac; Charles Hobson; Jay L Koyner; Andrew Shaw; George J Arnaoutakis; Xiaoqiang Ding; Daniel T Engelman; Hrvoje Gasparovic; Vladimir Gasparovic; Charles A Herzog; Kianoush Kashani; Nevin Katz; Kathleen D Liu; Ravindra L Mehta; Marlies Ostermann; Neesh Pannu; Peter Pickkers; Susanna Price; Zaccaria Ricci; Jeffrey B Rich; Lokeswara R Sajja; Fred A Weaver; Alexander Zarbock; Claudio Ronco; John A Kellum Journal: J Am Heart Assoc Date: 2018-06-01 Impact factor: 5.501
Authors: Lasith Adhikari; Tezcan Ozrazgat-Baslanti; Matthew Ruppert; R W M A Madushani; Srajan Paliwal; Haleh Hashemighouchani; Feng Zheng; Ming Tao; Juliano M Lopes; Xiaolin Li; Parisa Rashidi; Azra Bihorac Journal: PLoS One Date: 2019-04-04 Impact factor: 3.240